High Tide (HITI)
(Delayed Data from NSDQ)
$2.61 USD
+0.07 (2.76%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $2.59 -0.02 (-0.77%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth D Momentum A VGM
Brokerage Reports
0 items in cart
High Tide Inc. [HITI]
Reports for Purchase
Showing records 61 - 80 ( 82 total )
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Updating Model After 4Q21 Filing, Buy and $12 PT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
4Q21 Results Strong Despite Canadian Challenges
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Weekly ReHash: California To See Lots of Changes in 2022, Positive Developments
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Top Canadian Name, Updating 2022 Estimates On NuLeaf and Discount Retail
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Bolsters U.S. CBD Presence Through NuLeaf Acquisition
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
3Q21 Earnings Week I Preview: Expecting Subdued Reports, NT Value In Ancillary
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: High Tide Inc.
Industry: Medical - Products
Highlighting Undiscovered Investment Opportunities in Cannabis
Provider: Roth Capital Partners, Inc.
Analyst: Research Department
Company: High Tide Inc.
Industry: Medical - Products
Meetings Highlight More Than Just a Canadian Cannabis Retailer
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Enters U.K. Market Through Blessed CBD Acquisition
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
3Q21 Sales Beat, New Initiatives Drive Top Line Growth, Buy and $12 PT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
Company: High Tide Inc.
Industry: Medical - Products
High Tide Rising as Leading Cannabis Retailer, Initiate Buy, $12 PT
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S